Argentine Hemorrhagic Fever
Study Finds First Vaccine Against an Arenavirus Safe and Effective
Published in Medical Letter on the CDC and FDA, March 9th, 1998
Of 6,500 men participating in the vaccine efficacy trial, only one who was immunized with the live, attenuated virus actually developed laboratory-confirmed Argentine hemorrhagic fever (AHF).
J.I. Maiztegui, of the Instituto Nacional de Enfermedades Virales Humanas, and colleagues at the Instituto Nacional de Estudios sobre Virosis Hemoragicas, both in Pergamino, Argentina, and at the U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA, including senior author Dr. C.J. Peters, reported their work in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Conference Coverage (Retrovirus)
CDC: HAART Cuts AIDS Death Risk By 86 Percent - Conference Coverage (Blood Safety)
Lookback Study Points to Safety of Transfusion - Diagnostics (HIV)
Combination of ELISAs Is Reliable, Cost-Effective - Outbreaks
20 Years Later, New Pennsylvania Legionnaires' Cluster Reported - Political Unrest
Rwandan Ethnic War Responsible for TB Rise - Immunizations
U.S. Said Child Vaccinations At Record Levels - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
